CNT-FET biosensors enable the rapid, label-free detection of biomarkers such as miRNA or exosomal protein for breast cancer and CEA for lung cancer, allowing for early diagnosis and personalized treatment. The gene discussed is CEACAM5; the disease is lung carcinoma.